Literature DB >> 17163665

Gene silencing activity of siRNAs with a ribo-difluorotoluyl nucleotide.

Jie Xia1, Anne Noronha, Ivanka Toudjarska, Feng Li, Akin Akinc, Ravi Braich, Maria Frank-Kamenetsky, Kallanthottathil G Rajeev, Martin Egli, Muthiah Manoharan.   

Abstract

Recently, chemically synthesized short interfering RNA (siRNA) duplexes have been used with success for gene silencing. Chemical modification is desired for therapeutic applications to improve biostability and pharmacokinetic properties; chemical modification may also provide insight into the mechanism of silencing. siRNA duplexes containing the 2,4-difluorotoluyl ribonucleoside (rF) were synthesized to evaluate the effect of noncanonical nucleoside mimetics on RNA interference. 5'-Modification of the guide strand with rF did not alter silencing relative to unmodified control. Internal uridine to rF substitutions were well-tolerated. Thermal melting analysis showed that the base pair between rF and adenosine (A) was destabilizing relative to a uridine-adenosine pair, although it was slightly less destabilizing than other mismatches. The crystal structure of a duplex containing rFoA pairs showed local structural variations relative to a canonical RNA helix. As the fluorine atoms cannot act as hydrogen bond acceptors and are more hydrophobic than uridine, there was an absence of a well-ordered water structure around the rF residues in both grooves. siRNAs with the rF modification effectively silenced gene expression and offered improved nuclease resistance in serum; therefore, evaluation of this modification in therapeutic siRNAs is warranted.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17163665     DOI: 10.1021/cb600063p

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  33 in total

Review 1.  Novel modifications in RNA.

Authors:  Kelly Phelps; Alexi Morris; Peter A Beal
Journal:  ACS Chem Biol       Date:  2011-12-23       Impact factor: 5.100

2.  Synthesis of N2-alkyl-8-oxo-7,8-dihydro-2'-deoxyguanosine derivatives and effects of these modifications on RNA duplex stability.

Authors:  Arunkumar Kannan; Cynthia J Burrows
Journal:  J Org Chem       Date:  2010-12-30       Impact factor: 4.354

3.  Minor-groove-modulating adenosine replacements control protein binding and RNAi activity in siRNAs.

Authors:  Hayden Peacock; Erik Fostvedt; Peter A Beal
Journal:  ACS Chem Biol       Date:  2010-10-07       Impact factor: 5.100

4.  Measurement and theory of hydrogen bonding contribution to isosteric DNA base pairs.

Authors:  Omid Khakshoor; Steven E Wheeler; K N Houk; Eric T Kool
Journal:  J Am Chem Soc       Date:  2012-02-02       Impact factor: 15.419

5.  Steric restrictions of RISC in RNA interference identified with size-expanded RNA nucleobases.

Authors:  Armando R Hernández; Larryn W Peterson; Eric T Kool
Journal:  ACS Chem Biol       Date:  2012-06-12       Impact factor: 5.100

Review 6.  Chemical modification: the key to clinical application of RNA interference?

Authors:  David R Corey
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

Review 7.  Model systems for understanding DNA base pairing.

Authors:  Andrew T Krueger; Eric T Kool
Journal:  Curr Opin Chem Biol       Date:  2007-11-09       Impact factor: 8.822

Review 8.  Strategies, design, and chemistry in siRNA delivery systems.

Authors:  Yizhou Dong; Daniel J Siegwart; Daniel G Anderson
Journal:  Adv Drug Deliv Rev       Date:  2019-05-15       Impact factor: 15.470

9.  Promiscuous 8-alkoxyadenosines in the guide strand of an siRNA: modulation of silencing efficacy and off-pathway protein binding.

Authors:  Uday Ghanty; Erik Fostvedt; Rachel Valenzuela; Peter A Beal; Cynthia J Burrows
Journal:  J Am Chem Soc       Date:  2012-10-11       Impact factor: 15.419

Review 10.  Crystallographic studies of chemically modified nucleic acids: a backward glance.

Authors:  Martin Egli; Pradeep S Pallan
Journal:  Chem Biodivers       Date:  2010-01       Impact factor: 2.408

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.